Safe Use of Immuno-Oncology Therapies: Managed Care and Specialty Pharmacy Considerations

Safe Use of Immuno-Oncology Therapies: Managed Care and Specialty Pharmacy Considerations is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians and will be held from Jul 31, 2018 - Jul 31, 2019.

Credits: 1.5 hour (0.15 ceu)

Target Audience:
This accredited activity has been designed for managed care and specialty pharmacists.

Goal:
To inform and educate managed care and specialty pharmacists about immune-oncology therapies and pharmacist driven strategies to optimize patient care and outcomes.

Educational Objectives:
Upon completion of this program, participants should be better able to:
• Describe the mechanisms of action for IO agents and their roles in various cancer types.
• Assess the role in therapy for IO agents with regard to clinical treatment pathways and formulary considerations.
• Identify unique response patterns to IO therapy and their impact on practice.
• Demonstrate pharmacist-driven strategies to recognize and effectively manage immune-related adverse events.

Additional details will be posted as soon as they are available.